ArticleCureus2025
Assessment of Bone Mineral Density in Pediatric Patients With Acute Leukemia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of Vitamin D Receptor Gene Polymorphisms and Hypovitaminosis D with Reduced Bone Mineral Density in Survivors of Childhood Leukemia: A Study in Algerian Patients.Current issues in molecular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Acute lymphoblastic leukemia (ALL) is the most prevalent highly curable childhood cancer, with long-term survival rates exceeding those of most other cancers. However, concerns persist regarding the adverse effects of treatment, particularly on bone health. Children with ALL often experience complications such as impaired growth, bone loss, and endocrine irregularities. This study aims to assess bone mineral density (BMD) in pediatric ALL patients undergoing chemotherapy, shedding light on the overlooked issue of osteoporosis. Methodology A prospective, observational study was conducted from February 2018 to August 2019. Children and adolescents (aged 2-20 years) with ALL or acute myelogenous leukemia undergoing induction chemotherapy were included. Baseline characteristics, nutritional parameters, and biochemical data were collected. BMD was assessed using dual-energy X-ray absorptiometry (DEXA). Results Among 64 patients, the majority were males (67.18%), and 39.06% were aged 16-20 years. Low serum albumin levels (20.31%) and deficiencies in folate (25.00%), vitamin B12 (28.13%), and vitamin D (95.31%) were observed. DEXA scans revealed that 46.43% had osteopenia, 28.57% had osteoporosis, and 25% had normal BMD. Serum calcium and vitamin D levels fluctuated but were not statistically significant. Duration from diagnosis to treatment did not differ significantly between patients with poor prognosis and those who achieved remission (p = 0.222). Conclusions This study underscores the need to monitor bone health in pediatric ALL patients, with a focus on early intervention and specialized care to manage osteopenia and osteoporosis. Comprehensive nutritional and metabolic assessments are essential for their well-being during leukemia treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.